Walgreens Sells Itself to Sycamore... Not Amazon

PRIVATE EQUITY

Healthcare's CEOs' Reveal Sky-High Compensation

HEALTHCARE

Eli Lilly: The Biggest Threat to Ozempic

Price Target: $700 (19% upside)

MorphoSys: A New Biotech Play

Price Target: $10 (25% upside)

Intellia: Is Gene Editing The Future of Medicine?

Price Target: $44 (30% upside)

Eli Lilly's Chronic Pincer Move

Elevance Health: Profiting from the Wealthiest Generation

Price Target: $554 (18% upside)

Shockwave: The Sleeper in Biotech

Evotec: The Best AI Healthcare Play

AstraZeneca's AI Cancer Missiles

Price Target: $88 (19% upside)

How Eli Lilly is Abolishing Obesity

Price Target: $483 (15% upside)

Merck's Secret Weapon Against Cancer

Price Target: $140 (21% upside)

Intuitive Surgical: The Right Growth at the Right Time

Price Target: $340 (16% upside)

Illumina: A Famous Activist Coming Aboard

Zoetis: Diversified and Poised for Growth

Merck: Getting Closer To Solving Cancer

Intuitive Surgical: A Strong Return to Medical Normal

Eli Lilly: The Biggest Healthcare Advancement In A Decade

Illumina is About to Corner the DNA Market

Biogen: A Crossroads to Complete our Pharma Trifecta

Eli Lilly: A Solid Discount Before the Big Show

Price Target: $388 (28% upside)

Thermo Fischer Scientific: Pivoting to Growth

Price Target: $689 (21% upside)

Eli Lilly: Defeating America's Biggest Health Crisis

Price Target: $342 (20% upside)

Merck: Medical Breakthrough After Breakthrough

Price Target: $105 (24% upside)